Intuitive Surgical (NASDAQ:ISRG) Price Target Raised to $475.00 at Evercore ISI

Intuitive Surgical (NASDAQ:ISRG) had its price objective lifted by equities research analysts at Evercore ISI from $410.00 to $475.00 in a note issued to investors on Tuesday, Benzinga reports. The brokerage currently has an “in-line” rating on the medical equipment provider’s stock. Evercore ISI’s price objective would suggest a potential downside of 2.15% from the stock’s previous close.

ISRG has been the topic of several other research reports. Truist Financial boosted their price target on shares of Intuitive Surgical from $450.00 to $515.00 and gave the company a “buy” rating in a research report on Tuesday, July 16th. Barclays boosted their price target on shares of Intuitive Surgical from $430.00 to $490.00 and gave the company an “overweight” rating in a research report on Thursday, July 18th. Redburn Atlantic raised shares of Intuitive Surgical from a “neutral” rating to a “buy” rating and boosted their price target for the company from $380.00 to $510.00 in a research report on Friday, August 2nd. BTIG Research boosted their price target on shares of Intuitive Surgical from $469.00 to $494.00 and gave the company a “buy” rating in a research report on Wednesday, August 28th. Finally, Morgan Stanley upped their target price on shares of Intuitive Surgical from $375.00 to $460.00 and gave the company an “equal weight” rating in a research report on Monday, July 15th. Six research analysts have rated the stock with a hold rating and fifteen have given a buy rating to the company’s stock. According to MarketBeat, Intuitive Surgical currently has an average rating of “Moderate Buy” and a consensus price target of $449.70.

Intuitive Surgical Stock Down 1.2 %

Shares of Intuitive Surgical stock traded down $5.84 during trading hours on Tuesday, reaching $485.43. 438,321 shares of the company’s stock were exchanged, compared to its average volume of 1,486,136. Intuitive Surgical has a 1 year low of $254.85 and a 1 year high of $496.18. The company has a market capitalization of $172.18 billion, a P/E ratio of 87.53, a price-to-earnings-growth ratio of 5.39 and a beta of 1.39. The business has a fifty day moving average of $473.63 and a two-hundred day moving average of $429.56.

Intuitive Surgical (NASDAQ:ISRG) last released its earnings results on Thursday, July 18th. The medical equipment provider reported $1.78 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.54 by $0.24. The business had revenue of $2.01 billion during the quarter, compared to analyst estimates of $1.97 billion. Intuitive Surgical had a net margin of 27.65% and a return on equity of 13.04%. The company’s revenue for the quarter was up 14.5% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $1.18 earnings per share. As a group, research analysts predict that Intuitive Surgical will post 5.22 EPS for the current year.

Insider Buying and Selling

In other Intuitive Surgical news, insider Mark Brosius sold 2,115 shares of the stock in a transaction that occurred on Thursday, September 12th. The shares were sold at an average price of $491.91, for a total value of $1,040,389.65. Following the transaction, the insider now directly owns 295 shares in the company, valued at $145,113.45. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. In other Intuitive Surgical news, SVP Henry L. Charlton sold 40,243 shares of the stock in a transaction that occurred on Friday, August 23rd. The shares were sold at an average price of $486.84, for a total value of $19,591,902.12. Following the transaction, the senior vice president now directly owns 3,001 shares in the company, valued at $1,461,006.84. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, insider Mark Brosius sold 2,115 shares of the firm’s stock in a transaction that occurred on Thursday, September 12th. The stock was sold at an average price of $491.91, for a total transaction of $1,040,389.65. Following the transaction, the insider now owns 295 shares in the company, valued at $145,113.45. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 53,120 shares of company stock worth $25,528,753. Company insiders own 0.90% of the company’s stock.

Hedge Funds Weigh In On Intuitive Surgical

A number of hedge funds have recently modified their holdings of the business. Creekmur Asset Management LLC lifted its holdings in shares of Intuitive Surgical by 200.0% during the first quarter. Creekmur Asset Management LLC now owns 63 shares of the medical equipment provider’s stock worth $25,000 after purchasing an additional 42 shares during the period. Ridgewood Investments LLC purchased a new position in Intuitive Surgical in the 2nd quarter valued at $26,000. Able Wealth Management LLC purchased a new position in Intuitive Surgical in the 4th quarter valued at $28,000. Delos Wealth Advisors LLC grew its position in Intuitive Surgical by 380.0% in the 1st quarter. Delos Wealth Advisors LLC now owns 72 shares of the medical equipment provider’s stock valued at $29,000 after buying an additional 57 shares during the last quarter. Finally, LRI Investments LLC purchased a new position in Intuitive Surgical in the 1st quarter valued at $30,000. 83.64% of the stock is currently owned by hedge funds and other institutional investors.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.